Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

06 mai 2026 18h00 HE | Source: Revolution Medicines, Inc.

Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer

REDWOOD CITY, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today...
06 mai 2026 16h02 HE | Source: Revolution Medicines, Inc.

Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress

Daraxonrasib demonstrated unprecedented survival benefit in Phase 3 RASolute 302 trial in previously treated metastatic pancreatic cancer; detailed results will be presented in upcoming ASCO Plenary...
06 mai 2026 13h30 HE | Source: Custom Market Insights

Global RNA Targeting Small Molecule Drug Discovery Market Size/Share Worth USD 17.6 Billion by 2035 at a 22.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

Austin, TX, USA, May 06, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “RNA Targeting Small Molecule Drug Discovery Market Size, Trends and Insights By...
06 mai 2026 10h52 HE | Source: Redwood Logistics

Redwood Logistics® Releases AI in Logistics Report, Finding Only 13 Percent of Shippers Deploying AI Are Generating Quantifiable Results

CHICAGO, May 06, 2026 (GLOBE NEWSWIRE) -- Redwood Logistics (Redwood), one of North America’s leading modern fourth-party logistics (4PL) providers, today released its inaugural AI in Logistics...
06 mai 2026 08h35 HE | Source: 24/7 Market News and NeOnc Technology

Where Executives Are Doubling Down on Their Companies’ Fortunes

Insiders are buying shares of $NTHI, $RIVN, $SRAD, $NWBI, and $FGBI
06 mai 2026 08h30 HE | Source: Allogene Therapeutics, Inc.

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update

Conference Call and Webcast Scheduled for May 13, 2026 at 2 p.m. PT/5 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a...
06 mai 2026 08h30 HE | Source: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease

AGOURA HILLS, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a late-stage clinical biopharmaceutical company focused...
06 mai 2026 06h00 HE | Source: Gigamon Inc

Gigamon 2026 Survey: AI Now Drives 83 Percent of Breaches as Attackers Outpace Defenders

Gigamon released its 2026 Hybrid Cloud Security Survey, revealing AI’s impact on the shifting cyber threat landscape as attackers outpace defenders.
05 mai 2026 13h20 HE | Source: Global Virus Network

Hantavirus Cluster Linked to Cruise Ship Highlights Ongoing Zoonotic Risk and the Need for Vigilance

For hantavirus cluster, experts emphasize caution while underscoring the importance of environmental controls, early detection, and clear communication.
05 mai 2026 09h30 HE | Source: Causal Dynamics Lab

Causal Dynamics Lab outperforms Anthropic and OpenAI in multiple coding tests

Causal Dynamics Lab flagship product Cielara Code beat both Claude Code (Opus-4.6) and OpenAI Codex (GPT-5.4).

Page précédente